Concepedia

Sepideh Shaker

SS

4

Publications

192

Citations

4

H-Index

2003

Active since

Affiliations

Centre Hospitalier Universitaire Sainte-Justine(Current)

Université de Montréal

Sepideh Shaker is an author at Centre Hospitalier Universitaire Sainte-Justine specializing in pharmacotherapy, dna methylation, and pathology.

Top concepts

Publications per year

2003–2004

4

Publications

4

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

Sepideh Shaker, Mark L. Bernstein, Louise F. Momparler et al. · Leukemia Research · 2003 · 103 citations

, , +11

Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells

Jacynthe Gagnon, Sepideh Shaker, Mélanie Primeau et al. · Anti-Cancer Drugs · 2003 · 46 citations

Activation of expression of p15, p73 and E-cadherin in leukemic cells by different concentrations of 5-aza-2'-deoxycytidine (Decitabine).

Nuno Jorge Farinha, Sepideh Shaker, Maryse Lemaire et al. · PubMed · 2004 · 25 citations

Antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and depsipeptide on Raji lymphoma cells

Sepideh Shaker, Mark L. Bernstein, Richard L. Momparler · Oncology Reports · 2004 · 18 citations

Rows per page

1–4 of 4